Adaptive phase shift apparatus and method
    5.
    发明授权
    Adaptive phase shift apparatus and method 有权
    自适应相移装置和方法

    公开(公告)号:US09313073B2

    公开(公告)日:2016-04-12

    申请号:US14371232

    申请日:2012-01-12

    IPC分类号: H04L27/26 H04W88/08

    摘要: The invention discloses an adaptive phase shift method in a multi-carrier system, comprising: generating a group of one or more new phase values for corresponding one or more phase shift carriers, PSCs, based on quantization phase values; calculating and comparing a backward maximum power in an evaluation path with the group of one or more new phase values in one timeslot and a forward maximum power in a working path with current phase values in the timeslot; and adjusting phase of the PSCs based on the group of one or more new phase values if the calculated backward maximum power is less than the calculated forward maximum power. An adaptive phase shift apparatus is also disclosed. With the invention, complexity of the implementation is reduced and a small DPS block resource, low Hardware cost, low power consumption is also achieved.

    摘要翻译: 本发明公开了一种多载波系统中的自适应相移方法,包括:基于量化相位值,生成相应的一个或多个相移载波PSC的一个或多个新相位值组; 计算和比较评估路径中的后向最大功率与一个时隙中的一个或多个新相位值组和工作路径中的正向最大功率与时隙中的当前相位值进行比较; 以及如果所计算的后向最大功率小于所计算的正向最大功率,则基于一个或多个新相位值的组来调整所述PSC的相位。 还公开了一种自适应相移装置。 利用本发明,实现的复杂度降低,并且还实现了小的DPS块资源,低硬件成本,低功耗。

    Preparation and drug composition of bis-benzyl-isoquinoline class alkaloids
    6.
    发明授权
    Preparation and drug composition of bis-benzyl-isoquinoline class alkaloids 有权
    双苄基异喹啉类生物碱的制备和药物组成

    公开(公告)号:US06617335B1

    公开(公告)日:2003-09-09

    申请号:US10139217

    申请日:2002-05-02

    IPC分类号: C07D40102

    CPC分类号: C07D491/18

    摘要: This invention relates to the preparation of bis-isoquinoline derivatives of general formula (I) and salts thereof, which possesses multi-drug resistance (MDR) reversal activities. Drug compositions and formulations comprising bis-isoquinoline derivatives of general formula (I) and salts thereof are provided for use as sensitivity enhancers in cancer chemotherapy. Methods for inhibiting MDR by treatment with bis-isoquinoline derivatives are also provided.

    摘要翻译: 本发明涉及具有多重耐药性(MDR)反转活性的通式(I)的双异喹啉衍生物及其盐的制备。 提供包含通式(I)的双异喹啉衍生物及其盐的药物组合物和制剂用作癌症化学疗法中的敏感性增强剂。 还提供了通过用双异喹啉衍生物处理抑制MDR的方法。

    ADAPTIVE PHASE SHIFT APPARATUS AND METHOD
    7.
    发明申请
    ADAPTIVE PHASE SHIFT APPARATUS AND METHOD 有权
    自适应相移装置和方法

    公开(公告)号:US20140355727A1

    公开(公告)日:2014-12-04

    申请号:US14371232

    申请日:2012-01-12

    IPC分类号: H04L27/26

    摘要: The invention discloses an adaptive phase shift method in a multi-carrier system, comprising: generating a group of one or more new phase values for corresponding one or more phase shift carriers, PSCs, based on quantization phase values; calculating and comparing a backward maximum power in an evaluation path with the group of one or more new phase values in one timeslot and a forward maximum power in a working path with current phase values in the timeslot; and adjusting phase of the PSCs based on the group of one or more new phase values if the calculated backward maximum power is less than the calculated forward maximum power. An adaptive phase shift apparatus is also disclosed. With the invention, complexity of the implementation is reduced and a small DPS block resource, low Hardware cost, low power consumption is also achieved.

    摘要翻译: 本发明公开了一种多载波系统中的自适应相移方法,包括:基于量化相位值,生成相应的一个或多个相移载波PSC的一个或多个新相位值组; 计算和比较评估路径中的后向最大功率与一个时隙中的一个或多个新相位值组和工作路径中的正向最大功率与时隙中的当前相位值进行比较; 以及如果所计算的后向最大功率小于所计算的正向最大功率,则基于一个或多个新相位值的组来调整所述PSC的相位。 还公开了一种自适应相移装置。 利用本发明,实现的复杂度降低,并且还实现了小的DPS块资源,低硬件成本,低功耗。